CellSeed
7776
Def Consulting
4833
Leoclan
7681
Timee
215A
Bank of Innovation
4393
JP Stock MarketDetailed Quotes
4564 OncoTherapy Science
- 28
- 00.00%
20min DelayMarket Closed Mar 25 15:30 JST
7.61BMarket Cap-4.63P/E (Static)
29High27Low3.17MVolume28Open28Pre Close87.60MTurnover6452wk High1.33%Turnover Ratio271.64MShares1552wk Low-4.81EPS TTM6.66BFloat Cap863Historical HighLossP/E (Static)237.68MShs Float15Historical Low-6.05EPS LYR7.14%Amplitude--Dividend TTM7.60P/B100Lot Size--Div YieldTTM
About OncoTherapy Science Company
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.
Company Profile
Symbol4564
Company NameOncoTherapy Science
Founded2001-04-06
MarketTSE Growth
Employees54
Fiscal Year Ends03-31
Address11th Floor, Kanagawa Science Park R&D 3-2-1 Sakado
Zip Code210-0005
Phone044-201-6429
Websitewww.oncotherapy.co.jp
Company Executives
- Name
- Position
- Salary
- Junichi Shimada
- President and Chief Executive Officer
- --
- Paku zai Ken
- Chief Scientific Officer and Director of Management Division
- --
- Toshio Kato
- Chairman of the Board
- --
- Yuichi Komine
- Independent Director
- --
- Yoshio Mitsuki
- Independent Director
- --